Study Summary
This study is designed to explore the safety and efficacy for patients with relapsed and/or refractory B-cell lymphoblastic leukemia.
Want to learn more about this trial?
Request More InfoInterventions
RD06-03 cell injectionDRUG
The patients in this intervention will use RD06-03 cell injection with 3 dose dose 1: 1×10\^5 CAR+ T Cells/kg dose 2: 3×10\^5 CAR+ T Cells/kg dose 3: 5×10\^5 CAR+ T Cells/kg Dosage form: IV injection Frequency of administration：1 time
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Anhui Provincial Hospital | Hefei | Anhui | China |
| Union Hospital Tongji Medical College Huazhong University of Science and Technology | Wuhan | Hubei | China |